![Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/03197da1-e15f-4d52-bfd5-a54f3ccf9cec/gr1.gif)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet
![PDF) The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression PDF) The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression](https://i1.rgstatic.net/publication/321204141_The_potential_of_P2X7_receptors_as_a_therapeutic_target_including_inflammation_and_tumour_progression/links/5a14ecf1aca27273c9eb122a/largepreview.png)
PDF) The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
![Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial - The Lancet Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8d016857-d6b8-405c-a282-d1a9f3dbd355/gr1_lrg.gif)